Current Issue cover

Regen Suppliers Release Umbilical Stem Cell & Exosome Products

Contact Author

Thank you for your inquiry. Please note that the author cannot provide individual medical advice. Also, if you have a customer service question, email customer service at

Fill out my online form.

Regen Suppliers releases umbilical stem cell and exosome products used for regenerative aesthetic procedures involving hair, facial and sexual rejuvenation: ReBella and ReBellaXO.

Regen Suppliers has announced the release of ReBella and ReBellaXO, umbilical stem cell and exosome products used for regenerative esthetic procedures involving hair, facial and sexual rejuvenation.

Regenerative esthetic procedures are on the rise and Regen Suppliers represents cost-efficient and safe patient care for regenerative biologics. Both biologics are supplied in 1cc, and the company has the goal of making it easier for medical providers to fit regenerative biologics into their esthetic pricing model.

“We wanted to give medical providers a safe, cost-effective product with no foreign reagents and a high cell count,” said Regen Suppliers president John Krall. “Our ReBella and ReBellaXO products demonstrate our dedication to safety and quality, and we are very excited to release this to medical providers and esthetic practices nationwide.”

ReBella, an Umbilical Allograft Biologic, is cryopreserved cord blood tissue that is a minimally manipulated allograft derived from full-term, post-c-section umbilical cord blood tissue and Wharton's Jelly. The tissue includes cytokines, growth factors, mRNA, exosomes, collagen, stem cells and other regenerative elements with exceptional viability and cellular activity.

Regen Suppliers processing system preserves high levels of donor stem cells, exosomes and viability per unit after cryopreservation including structural proteins, collagen and hyaluronic acid, which work homologously with one's body.

ReBella works to maintain high cell counts and variability of cell types due to its careful handling and processing in a GMP compliant clean room.

ReBellaXO, an MSC Derived Exosome Biologic, is also a minimally manipulated allograft derived from full-term, post-c-section umbilical cord tissue and Wharton's Jelly. It is an exosome allograft derived from Wharton's Jelly MSCs and is sourced from a proprietary blend of cells developed for growth and repair.

Exosomes and other Extracellular Vesicles (EVs) are isolated from their parent cells and concentrated to produce the Exosomal Product.

ReBellaXO is processed from donated umbilical cords from full-term deliveries. All donors are pre-screened and undergo comprehensive testing that includes behavioral risk assessment, physical assessment, donor medical history and communicable disease testing.

Both of these products can be traced to the individual donor as well as to the exact day and time of the tissue processing. These biologics come from FDA regulated labs and Regen Suppliers ensures that safety standards exceed FDA regulations.

Related Content